Pancreatin is a mixture of several digestive enzymes
produced by the exocrine cells of the pancreas. Pancreatin is usually obtained
from the pancreas of pigs or cows. The pancreas is an organ in animals and
people that makes chemicals - amylase, lipase, and protease - that are needed
for proper digestion. This mixture is used to treat conditions in which
pancreatic secretions are deficient, such as surgical pancreatectomy,
pancreatitis and cystic fibrosis.
Pancreatin contains the pancreatic enzymes trypsin, amylase and lipase. A similar mixture of enzymes is sold as pancrelipase, which contains more active lipase enzyme than does pancreatin. The trypsin found in pancreatin works to hydrolyze proteins into oligopeptides; amylase hydrolyzes starches into oligosaccharides and the disaccharide maltose; and lipase hydrolyzes triglycerides into fatty acids and glycerols. Pancreatin is an effective enzyme supplement for replacing missing pancreatic enzymes, and aids in the digestion of foods in cases of pancreatic insufficiency. Pancreatin reduces the absorption of iron from food in the duodenum during digestion.
Pancreatin production, which measures output worldwide, was expected to reach 2,556 tons in 2016 with an increase of 4.07% from its year-earlier level. The global pancreatin market size is estimated to grow from USD 72.1 million in 2011 to USD 89.18 million by 2016, at an estimated CAGR of 4.34% between 2011 and 2016. With regards to this, key players of pancreatin industry are expected to find potential opportunities in this market.
The global pancreatin market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global pancreatin market are Shenzhen Hepalink, Nordmark, Sichuan Deebio, ALI, Chongqing Jingkang, Chongqing Aoli, Sichuan Biosyn, Biocatalysts, Bovogen Biologicals, Tinshui Chrestensen, etc.
Pancreatin contains the pancreatic enzymes trypsin, amylase and lipase. A similar mixture of enzymes is sold as pancrelipase, which contains more active lipase enzyme than does pancreatin. The trypsin found in pancreatin works to hydrolyze proteins into oligopeptides; amylase hydrolyzes starches into oligosaccharides and the disaccharide maltose; and lipase hydrolyzes triglycerides into fatty acids and glycerols. Pancreatin is an effective enzyme supplement for replacing missing pancreatic enzymes, and aids in the digestion of foods in cases of pancreatic insufficiency. Pancreatin reduces the absorption of iron from food in the duodenum during digestion.
Pancreatin production, which measures output worldwide, was expected to reach 2,556 tons in 2016 with an increase of 4.07% from its year-earlier level. The global pancreatin market size is estimated to grow from USD 72.1 million in 2011 to USD 89.18 million by 2016, at an estimated CAGR of 4.34% between 2011 and 2016. With regards to this, key players of pancreatin industry are expected to find potential opportunities in this market.
The global pancreatin market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global pancreatin market are Shenzhen Hepalink, Nordmark, Sichuan Deebio, ALI, Chongqing Jingkang, Chongqing Aoli, Sichuan Biosyn, Biocatalysts, Bovogen Biologicals, Tinshui Chrestensen, etc.
To Browse Complete Report visit @ https://www.reportsmonitor.com/global-pancreatin-market-outlook-2016-2021/
Table of Contents
Part 1. Scope of
Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
1.4 Key Findings
1.2 Geographic Scope
1.3 Years Considered
1.4 Key Findings
Part 2. Introduction
2.1 Definition
2.2 Mechanism of Action of Pancreatin
Part 3.
Manufacture
3.1 Manufacturing Technologies
3.2 Value Chain Analysis
3.2.1 Upstream
3.2.2 Downstream
3.1 Manufacturing Technologies
3.2 Value Chain Analysis
3.2.1 Upstream
3.2.2 Downstream
Part 4. Cost Structure
4.1 Bill of Materials (BOM)
4.2 Labor Costs
4.3 Manufacturing Costs
Part 5. Worldwide Key Vendors
5. Worldwide Key Vendors
5.1 ALI (USA)
5.2 Biocatalysts (UK)
5.3 Nordmark (Germany)
5.4 Bovogen Biologicals (Australia)
5.5 Rossari (India)
5.6 Costantino (Italy)
5.7 Shenzhen Hepalink (China)
5.8 Sichuan Deebio (China)
5.9 Beijing Geyuantianrun (China)
5.10 Chongqing Aoli (China)
5.11 Deyang Sinozyme (China)
5.12 Sichuan Biosyn (China)
5.13 Sichuan Friendly (China)
5.14 Chongqing Jingkang (China)
5.15 Hubei Lvjinzi (China)
5.15 Tinshui Chrestensen (China)
5.16 Changzhishi Sanbao (China)
Contact Us
Jay Mathews
Direct: +1 513 549-5911
No comments:
Post a Comment